Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts

Youssef M Mousa1, Ihab M Abdallah1, Misako Hwang2

  • 1Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, USA.

Scientific Reports
|March 1, 2020
PubMed

Insights

Amylin and pramlintide, peptides linked to type 2 diabetes, worsen Alzheimer's disease (AD) pathology by increasing amyloid-beta (Aβ) burden in the brain. This suggests elevated amylin or pramlintide use may heighten AD risk.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Endocrinology

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) peptide accumulation.
  • Similarities between Aβ and human amylin have suggested a link between AD and type 2 diabetes.

Purpose of the Study:

  • To investigate the effects of amylin and pramlintide on Aβ pathogenesis in a mouse model of cerebral amyloid angiopathy (CAA) and AD.
  • To elucidate the molecular mechanisms underlying these effects.

Main Methods:

  • TgSwDI mice, an AD and CAA model, received daily intraperitoneal injections of amylin or pramlintide for 30 days.
  • Brain Aβ burden, amyloidogenic pathway modulation (APP, γ-secretase), ganglioside levels (GM1, GM2), and neuropathological markers (synaptic loss, apoptosis, microglia activation) were assessed.

Main Results:

  • Amylin and pramlintide treatments significantly increased Aβ burden in mouse brains.
  • Both peptides altered the amyloidogenic pathway by modulating amyloid precursor protein (APP) and γ-secretase levels within lipid rafts.
  • Increased GM1 and GM2 ganglioside levels were observed, correlating with altered amyloidogenic pathway proteins and contributing to increased Aβ burden, synaptic loss, apoptosis, and microglia activation.

Conclusions:

  • Amylin and pramlintide administration exacerbate Aβ pathology and associated neuropathological changes in TgSwDI mice.
  • These findings suggest that elevated amylin levels or therapeutic use of pramlintide could potentially increase the risk of developing Alzheimer's disease.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
761
Membrane Asymmetry Regulating Transporters01:19

Membrane Asymmetry Regulating Transporters

Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
6.8K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
9.2K
Membrane Fluidity01:26

Membrane Fluidity

Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
14.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.0K